YieldBoost MET To 13.5% Using Options

MetLife (MET) is trading at $78.73 with an annualized dividend yield of about 2.9% and a trailing 12-month volatility of 28%, with dividend history cited as a guide to payout durability. The piece evaluates a covered-call trade (September $80 strike) as a risk/reward decision and notes broader options flow: S&P 500 put volume 761,389 vs. call volume 1.40M for a put:call ratio of 0.54 (below the long-term median of 0.65), indicating relatively stronger call demand today.

Analysis

Market structure: Elevated call flow and a 0.54 put:call ratio indicate short-term bullish positioning that benefits call sellers (premium harvest) and liquidity providers while increasing gamma risk for dealers if MET moves toward $80. Life/annuity carriers like MET are indirect beneficiaries of higher long-term yields (investment income expands if 10y > ~3.5%), while high underwriting volatility or catastrophe losses would hurt earnings and dividend sustainability. Cross-asset: stronger rates tighten insurer ALM mismatches (positive for equity if reinvestment yields > hurdle) and push bond spreads tighter; FX/commodities limited direct impact here.

Risk assessment: Tail risks include a dividend cut from reserve shocks or mark-to-market losses if credit spreads widen >100bp, regulatory capital actions, or a sudden unwind of call crowding that triggers a sharp pullback (>10% in days). Immediate (days) risk is options-flow driven volatility; short-term (weeks–months) hinges on quarterly results and 10y rate moves; long-term (12–24 months) depends on realized investment returns and execution on capital returns. Hidden dependencies: MET’s earnings sensitivity to reinvestment rates, loss reserves, and reinsurance availability; catalysts include Fed policy shifts, major catastrophe events, and MET earnings/primary reserve disclosures.

Trade implications: Direct: establish a 2–3% long position in MET via a buy-write (buy MET, sell Sep ~$80 calls) to harvest dividend (~2.9%) and time premium; size to portfolio volatility. Hedged alternative: collar the position by buying 3‑month 5% OTM puts if drawdown protection desired (cost cap ~1–2% depending on IV). Relative/value: pair long MET (2%) vs short TRV (1–1.5%) to express yield sensitivity over pure P&C underwriting exposure; if expecting short-term IV compression, implement bearish call spreads (sell 30‑day ATM, buy 10–15% OTM) rather than naked shorts.

Contrarian angles: Consensus buoyancy from call-heavy flows may be overstated — if 10y falls below 3.0% or MET trades < $70, dividend cut probability meaningfully rises and calls can unwind violently; that risk appears underpriced given only a 2.9% yield. Historical parallels (insurer dividend cuts in stressed rate/credit regimes) argue for option-protected exposure rather than naked long. Unintended consequence: buy-write sellers cap upside and may miss re-rating if MET is rerated for higher ROE; set explicit exits (roll calls if MET > $85 or trim if 10y <3.0%).

Key Decisions for Investors

• Establish a 2–3% long position in MET via buy-write: buy shares and sell Sep $80 calls (≈30–60 day expiry), target net yield pickup >2.5% annualized; roll or close if MET > $85 or if 10y US Treasury yield falls below 3.0%.
• If downside protection desired, collar the above position by buying 3‑month 5% OTM puts (cost-limited to ~1–2% of position) to cap a >10% drawdown over the next quarter.
• Implement a relative-value pair: go long MET (2%) and short TRV (1–1.5%) to express duration/rate-sensitive upside versus P&C underwriting exposure; reassess after MET quarterly results or if 10y moves ±50bp.
• If trading volatility: sell 30‑day ATM MET calls and buy 10–15% OTM calls (bear call spread) size = 0.5–1% notional to monetize elevated short-term call demand; close if implied vol falls >5 vol points or MET gaps >6% intraday.